Debt-to-equity of Karyopharm Therapeutics Inc. from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Karyopharm Therapeutics Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • Karyopharm Therapeutics Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was -143%, a 35% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Karyopharm Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -143% +76% +35% 31 Dec 2025
Q3 2025 -155% +87% +36% 30 Sep 2025
Q2 2025 -174% +99% +36% 30 Jun 2025
Q1 2025 -202% +111% +35% 31 Mar 2025
Q4 2024 -219% +202% +48% 31 Dec 2024
Q3 2024 -242% +394% +62% 30 Sep 2024
Q2 2024 -273% +271% +50% 30 Jun 2024
Q1 2024 -312% +156% +33% 31 Mar 2024
Q4 2023 -421% -1.4% -0.32% 31 Dec 2023
Q3 2023 -636% -277% -77% 30 Sep 2023
Q2 2023 -544% -170% -45% 30 Jun 2023
Q1 2023 -468% -61% -15% 31 Mar 2023
Q4 2022 -420% +21% +4.9% 31 Dec 2022
Q3 2022 -359% +310% +46% 30 Sep 2022
Q2 2022 -374% -10774% -104% 30 Jun 2022
Q1 2022 -407% -888% -184% 31 Mar 2022
Q4 2021 -441% -678% -287% 31 Dec 2021
Q3 2021 -669% -902% -388% 30 Sep 2021
Q2 2021 10400% +10158% +4190% 30 Jun 2021
Q1 2021 482% +234% +94% 31 Mar 2021
Q4 2020 236% -20% -8% 31 Dec 2020
Q3 2020 233% +72% +45% 30 Sep 2020
Q2 2020 242% +148% +156% 30 Jun 2020
Q1 2020 248% +188% +311% 31 Mar 2020
Q4 2019 257% +211% +466% 31 Dec 2019
Q3 2019 161% +129% +405% 30 Sep 2019
Q2 2019 95% +66% +228% 30 Jun 2019
Q1 2019 60% +33% +125% 31 Mar 2019
Q4 2018 45% +26% +138% 31 Dec 2018
Q3 2018 32% +19% +152% 30 Sep 2018
Q2 2018 29% +18% +158% 30 Jun 2018
Q1 2018 27% +16% +141% 31 Mar 2018
Q4 2017 19% +8.8% +87% 31 Dec 2017
Q3 2017 13% +3.1% +33% 30 Sep 2017
Q2 2017 11% +2.4% +27% 30 Jun 2017
Q1 2017 11% +3.5% +46% 31 Mar 2017
Q4 2016 10% +3.2% +46% 31 Dec 2016
Q3 2016 9.5% +3% +45% 30 Sep 2016
Q2 2016 8.8% +3.2% +58% 30 Jun 2016
Q1 2016 7.6% +2.5% +48% 31 Mar 2016
Q4 2015 7% 31 Dec 2015
Q3 2015 6.6% 30 Sep 2015
Q2 2015 5.6% 30 Jun 2015
Q1 2015 5.2% 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.